Hoybergs Yves M J J, Meert Theo F
CNS Discovery Research, Johnson & Johnson Pharmaceutical Research & Development, Turnhoutseweg 30, B-2340 Beerse, Belgium.
Neurosci Lett. 2007 May 1;417(2):149-54. doi: 10.1016/j.neulet.2007.02.087. Epub 2007 Mar 19.
The pathogenesis of diabetic neuropathy is multifactorial, but in general hyperglycemia through polyol and protein glycation pathways is considered to be a key etiological factor. Most likely insulin deficiency, in experimentally induced type I diabetes, contributes to the development of diabetes neuropathy. The aim of this study was to evaluate the in vivo behavioral effect of low-dose insulin on diabetic neuropathy in rats through behavioral testing in hyperglycemic conditions. Mechanical sensitivity and allodynia were tested in streptozotocin (STZ)-induced diabetic rats. After diabetes and neuropathy induction, treatment with low-dose insulin normalized behavioral test results in 37 days, while severe hyperglycemia persisted. Although this study provided no evidence about the role of hypoinsulinemia in the etiology of diabetes neuropathy, the results confirmed that an insulin deficit with impaired insulin signaling and neurotrophic support, rather than hyperglycemia, plays an essential role in the pathophysiology of painful diabetic neuropathy.
糖尿病神经病变的发病机制是多因素的,但一般认为高血糖通过多元醇和蛋白质糖基化途径是关键的病因因素。在实验诱导的I型糖尿病中,胰岛素缺乏很可能促成了糖尿病神经病变的发展。本研究的目的是通过在高血糖条件下的行为测试,评估低剂量胰岛素对大鼠糖尿病神经病变的体内行为影响。在链脲佐菌素(STZ)诱导的糖尿病大鼠中测试了机械敏感性和异常性疼痛。在诱导糖尿病和神经病变后,低剂量胰岛素治疗在37天内使行为测试结果恢复正常,而严重高血糖持续存在。尽管本研究没有提供关于低胰岛素血症在糖尿病神经病变病因中作用的证据,但结果证实,胰岛素缺乏伴胰岛素信号传导和神经营养支持受损,而非高血糖,在疼痛性糖尿病神经病变的病理生理学中起重要作用。